Tuesday, 27 April 2010 at 10:22, Bloomberg
GlaxoSmithKline Pharmaceuticals Ltd, the Indian unit of the UK’s biggest drugmaker, was downgraded to “reduce” from “neutral” by Sarabjit Kour Nangra, an analyst at Angel Broking Ltd in Mumbai. The brokerage cited valuations for the reduction in an e-mailed note to clients today.
Your comments